Diebold Nixdorf, Incorporated
DBD
$75.36
-$2.12-2.74%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.03% | 11.66% | 1.95% | -2.61% | -6.06% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.03% | 11.66% | 1.95% | -2.61% | -6.06% |
| Cost of Revenue | 6.16% | 6.91% | 1.75% | -3.33% | -6.26% |
| Gross Profit | 5.63% | 26.78% | 2.52% | -0.53% | -5.50% |
| SG&A Expenses | 0.21% | -5.33% | 2.84% | 4.23% | 0.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 164.71% | -166.67% | -93.33% | 105.56% | -70.00% |
| Total Operating Expenses | 5.51% | 4.46% | 1.42% | -1.83% | -5.20% |
| Operating Income | 14.31% | 135.79% | 7.60% | -10.82% | -18.02% |
| Income Before Tax | 215.46% | 424.37% | 525.61% | -62.61% | 43.27% |
| Income Tax Expenses | 359.09% | 116.36% | -67.89% | -85.00% | 29.03% |
| Earnings from Continuing Operations | 173.33% | 689.06% | 292.17% | -14.19% | 46.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 37.50% | -12.50% | 14.29% | -600.00% | -33.33% |
| Net Income | 160.24% | 785.71% | 283.48% | -18.12% | 43.15% |
| EBIT | 14.31% | 135.79% | 7.60% | -10.82% | -18.02% |
| EBITDA | 5.51% | 65.58% | 6.49% | -7.00% | -10.98% |
| EPS Basic | 164.57% | 830.49% | 289.02% | -17.23% | 43.16% |
| Normalized Basic EPS | 308.61% | 263.65% | 58.21% | -42.06% | -51.61% |
| EPS Diluted | 163.43% | 815.58% | 285.00% | -17.23% | 43.16% |
| Normalized Diluted EPS | 301.73% | 258.66% | 56.08% | -42.36% | -51.61% |
| Average Basic Shares Outstanding | -6.65% | -4.79% | -2.93% | -1.06% | 0.00% |
| Average Diluted Shares Outstanding | -5.05% | -3.46% | -1.60% | -0.53% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |